» Articles » PMID: 26870188

Association Between the Rs11614913 Variant of MiRNA-196a-2 and the Risk of Epithelial Ovarian Cancer

Overview
Journal Oncol Lett
Specialty Oncology
Date 2016 Feb 13
PMID 26870188
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Polymorphisms in microRNA (miR) genes and their target sites are a distinct classification of variation in the human genome, which are rapidly being identified and investigated in human cancer. A polymorphism in the miR-196a-2 locus has demonstrated significant associations with various types of cancer, including lung, breast, esophageal and gastric tumors. However, miR-196a-2 has not been fully explored in ovarian cancer, which shares similar biological characteristics with other types of cancer. Therefore, the present study aimed to elucidate the association between a single nucleotide polymorphism (SNP) in the mature sequence of miR-196a-2 (rs11614913, T/C) and the clinical features of 479 Chinese patients with epithelial ovarian cancer (EOC). In addition, the biological significance of this polymorphism was investigated in the OVCAR3 ovarian cancer cell line. Risk association was evaluated in 479 cases of EOC patients and 431 controls. SNPs were analyzed by using polymerase chain reaction based restriction fragment length polymorphism assay. miR-196a expression was evaluated with reverse transcription polymerase chain reaction. The influence of miR-196a-2 rs11614913 T/C on EOC cell migration and invasion ability was further investigated . The results revealed significant differences in the homozygous CC genotype distribution in patients with EOC (n=479), compared with that of the control subjects (n=431; P=0.026). Analysis of the association between genotype and the risk of EOC revealed that individuals who carried the homozygous CC genotype were 1.34-fold more susceptible to EOC, compared with those carrying the wild-type TT and heterozygous CT genotypes [odds ratio, 1.34; 95% confidence interval, 1.04-2.17; P=0.023]. In addition, the role of this polymorphism in the production of mature miR-196a was investigated. Significantly enhanced production of mature miR-196a was revealed in the C-allelic compared with that of the T-allelic miR-196a-2 precursor (P<0.05). Further examination indicated that miR-196a significantly promoted cell migration and invasion ability in the human OVCAR3 ovarian cell line (P<0.05). In conclusion, the results indicated that the miR-196a-2 rs11614913 CC genotype may increase the risks of ovarian cancer by affecting the expression of mature miR-196a and enhancing cell migration/invasion. The current results provided evidence that the T>C polymorphism in the miR-196a-2 precursor may influence tumorigenesis and metastasis in EOC, and suggested that the functional SNP rs11614913 in the promoter region of pri-miR-196a-2 may be a potential indicator of EOC susceptibility in the population analyzed.

Citing Articles

The clinicopathological role of miRNA-196a and its SNP variant rs11614913 in high-grade ovarian cancer.

Lesniak E, Stec-Martyna E, Domanska-Senderowska D, Romanowicz H, Krawczyk T, Bienkiewicz J Prz Menopauzalny. 2025; 23(4):180-184.

PMID: 39811383 PMC: 11726191. DOI: 10.5114/pm.2024.145949.


Identification and validation of immunity- and disulfidptosis-related genes signature for predicting prognosis in ovarian cancer.

Jin M, Ni D, Cai J, Yang J Heliyon. 2024; 10(12):e32273.

PMID: 38952356 PMC: 11215265. DOI: 10.1016/j.heliyon.2024.e32273.


Functional Variants in MicroRNAs (rs895819, rs11614913 and rs2910164) Are Associated with Susceptibility and Clinicopathological Features in Mexican Patients with Colorectal Cancer.

Trujillo-Fernandez Y, Yzabal-Barbedillo C, Saucedo-Sarinana A, Tovar-Jacome C, Godinez-Rodriguez M, Barros-NuneZ P Arch Iran Med. 2024; 26(8):439-446.

PMID: 38301106 PMC: 10685737. DOI: 10.34172/aim.2023.67.


High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive.

Wilczynski J, Paradowska E, Wilczynski M Biomedicines. 2024; 12(1).

PMID: 38275400 PMC: 10813374. DOI: 10.3390/biomedicines12010229.


Associations between non-coding RNAs genetic polymorphisms with ovarian cancer risk: A systematic review and meta-analysis update with trial sequential analysis.

Liu H, Sun L, Liu X, Wang R, Luo Q Medicine (Baltimore). 2023; 102(39):e35257.

PMID: 37773807 PMC: 10545158. DOI: 10.1097/MD.0000000000035257.


References
1.
Prat J . Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2013; 124(1):1-5. DOI: 10.1016/j.ijgo.2013.10.001. View

2.
Xu Q, Dong Q, He C, Liu W, Sun L, Liu J . A new polymorphism biomarker rs629367 associated with increased risk and poor survival of gastric cancer in chinese by up-regulated miRNA-let-7a expression. PLoS One. 2014; 9(4):e95249. PMC: 3997364. DOI: 10.1371/journal.pone.0095249. View

3.
Wienholds E, Plasterk R . MicroRNA function in animal development. FEBS Lett. 2005; 579(26):5911-22. DOI: 10.1016/j.febslet.2005.07.070. View

4.
Eitan R, Kushnir M, Lithwick-Yanai G, David M, Hoshen M, Glezerman M . Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol Oncol. 2009; 114(2):253-9. DOI: 10.1016/j.ygyno.2009.04.024. View

5.
Slaby O, Bienertova-Vasku J, Svoboda M, Vyzula R . Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J Cell Mol Med. 2011; 16(1):8-21. PMC: 3823089. DOI: 10.1111/j.1582-4934.2011.01359.x. View